Synthaverse S.A. (FRA:6NQ)

Germany · Delayed Price · Currency is EUR

0.6190

-0.0040 (-0.64%)

At close: Jun 26, 2026

-46.45% (1Y)

Market Cap	46.93M -44.5%
Revenue (ttm)	9.82M -40.8%
Net Income	-5.35M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.6260
Previous Close	0.6230
Day's Range	0.6190 - 0.6260
52-Week Range	0.5930 - 1.2540
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Synthaverse

Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally. It operates through BCG and Traditional segments. The company offers OnkoBCG 50 and 100, which are oncological immunotherapy products used to treat superficial and non-invasive bladder tumors; GAMMA anty-D 50 and GAMMA anty-D 150, which are human anti-rh0(d) immunoglobulin products used in the prevention of maternal-fetal conflict in terms of the D antigen... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1944

Employees 214

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 6NQ

Financial Performance

Financial numbers in PLN Financial Statements